168 related articles for article (PubMed ID: 1489900)
1. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
Patrassi GM; Sartori MT; Viero ML; Scarano L; Boscaro M; Girolami A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):789-93. PubMed ID: 1489900
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
Erem C; Nuhoglu I; Yilmaz M; Kocak M; Demirel A; Ucuncu O; Onder Ersoz H
J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
[TBL] [Abstract][Full Text] [Related]
5. Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment.
Patrassi GM; Sartori MT; Rigotti P; Di Landro D; Theodoridis P; Fioretti M; Capalbo M; Saggiorato G; Boeri G; Girolami A
Transplantation; 1995 May; 59(10):1416-20. PubMed ID: 7770928
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and fibrinolytic systems in type I diabetes: effects of venous occlusion and insulin-induced hypoglycaemia.
Wieczorek I; Pell AC; McIver B; MacGregor IR; Ludlam CA; Frier BM
Clin Sci (Lond); 1993 Jan; 84(1):79-86. PubMed ID: 8382139
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
Stegnar M; Mavri A
Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.
Avellone G; Di Garbo V; Cordova R; Raneli G; De Simone R; Bompiani GD
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):429-33. PubMed ID: 8329569
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.
Pecori Giraldi F; Ambrogio AG; Fatti LM; Rubini V; Cozzi G; Scacchi M; Federici AB; Cavagnini F
Br J Clin Pharmacol; 2011 Jan; 71(1):132-6. PubMed ID: 21143510
[TBL] [Abstract][Full Text] [Related]
11. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation.
Patrassi GM; Sartori MT; Livi U; Casonato A; Danesin C; Vettore S; Girolami A
Transplantation; 1997 Dec; 64(11):1610-4. PubMed ID: 9415568
[TBL] [Abstract][Full Text] [Related]
12. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.
Kastelan D; Dusek T; Kraljevic I; Polasek O; Giljevic Z; Solak M; Salek SZ; Jelcic J; Aganovic I; Korsic M
Endocrine; 2009 Aug; 36(1):70-4. PubMed ID: 19381886
[TBL] [Abstract][Full Text] [Related]
13. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
[TBL] [Abstract][Full Text] [Related]
14. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
[TBL] [Abstract][Full Text] [Related]
15. Further studies on the hypercoagulable state of patients with Cushing's syndrome.
Patrassi GM; Dal Bo Zanon R; Boscaro M; Martinelli S; Girolami A
Thromb Haemost; 1985 Aug; 54(2):518-20. PubMed ID: 4082087
[TBL] [Abstract][Full Text] [Related]
16. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
[TBL] [Abstract][Full Text] [Related]
17. Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients.
Sartori MT; Patrassi GM; Rigotti P; Marchini F; Fioretti M; Spiezia L; Girolami A
Transplantation; 2000 May; 69(10):2116-21. PubMed ID: 10852608
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of glucocorticoids: coagulopathy.
Coelho MC; Santos CV; Vieira Neto L; Gadelha MR
Eur J Endocrinol; 2015 Oct; 173(4):M11-21. PubMed ID: 25971647
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
20. Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state.
Dal Bo Zanon R; Fornasiero L; Boscaro M; Cappellato G; Fabris F; Girolami A
Thromb Haemost; 1982 Apr; 47(2):116-7. PubMed ID: 6808692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
